Taken together, the results mentioned previously indicated that GRK2 expression increased not only in the cardiomyocytes of DCM but also in PBMCs of patients with LVDD, thus GRK2 might serve as a biomarker of early DCM. Here, GRK2 is linked to familial dilated cardiomyopathy.